Join
Live feed
·
INSIDERFilingvia Quantisnow
Akebia Therapeutics Inc. logo

CEO and President Butler John P. sold $474,414 worth of shares (341,305 units at $1.39) and was granted 175,250 shares, decreasing direct ownership by 5% to 3,297,794 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AKBA (Akebia Therapeutics Inc.) and more on Quantisnow.